A Bayesian approach towards the identification of latent subgroups

Area of Science:

• Biostatistics
• Clinical Trial Methodology
• Health Outcomes Research

Background:

• Identifying heterogeneity of treatment effect is crucial in clinical trials but challenging due to limited statistical power and difficulty in defining patient subgroups.
• Subgroup analysis is complex, often requiring specialized statistical methods to detect differential treatment responses.

Purpose of the Study:

• To propose a novel semiparametric mixture model for identifying subgroups with distinct time-to-event outcomes.
• To address the challenges in subgroup analysis by incorporating patient prognostic factors and accounting for classification uncertainty.

Main Methods:

• Utilized a proportional hazards model with subgroup-specific piecewise constant baseline hazards.
• Employed a Bayesian approach to handle classification uncertainty and model subgroup membership as a function of prognostic factors.
• Assumed consistent subgroup-specific treatment effects within identified subgroups.

Main Results:

• Demonstrated the model's utility through simulation studies, validating its performance in identifying subgroups.
• Applied the method to a real-world clinical trial dataset from HIV research, showcasing practical applicability.
• Successfully identified patient subgroups exhibiting differential treatment effects.

Conclusions:

• The proposed semiparametric mixture model offers a robust framework for identifying treatment effect heterogeneity in time-to-event data.
• This Bayesian approach effectively incorporates patient characteristics to define subgroups and accounts for uncertainty in subgroup assignment.
• The method provides valuable insights for personalized medicine and optimizing treatment strategies in clinical practice.